MgO nanoparticles coated with polyethylene glycol as carrier for 2-Methoxyestradiol anticancer drug

Doxorubicin Loaded Magnesium Oxide Nanoflakes as pH Dependent Carriers for Simultaneous Treatment of Cancer and Hypomagnesemia

(2019) Tharindu Ranathunge et al.   Nanomaterials

In vitro evaluation of the toxic effects of MgO nanostructure in Hela cell line

(2018) M. Waseem Akram et al.   Scientific Reports

Albumin binding and anticancer effect of magnesium oxide nanoparticles

(2018) Elham Behzadi et al.   International Journal of Nanomedicine

FTIR and Raman Characterization of TiO2 Nanoparticles Coated with Polyethylene Glycol as Carrier for 2-Methoxyestradiol

(2017) Andrea León et al.   Applied Sciences-Basel

In Vitro Toxicological Assessment of Magnesium Oxide Nanoparticle Exposure in Several Mammalian Cell Types

(2016) Abudayyak Mahmoud et al.   INTERNATIONAL JOURNAL OF TOXICOLOGY

MgO Nanoparticles for Effective Uptake and Release of Doxorubicin Drug: pH Sensitive Controlled Drug Release

(2016) Thirunavukkarasu Somanathan et al.   JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY

Can Be a Bimetal Oxide ZnO—MgO Nanoparticles Anticancer Drug Carrier and Deliver? Doxorubicin Adsorption/Release Study

(2015) Raju Kumar et al.   JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY

Trends in Metastatic Breast and Prostate Cancer — Lessons in Cancer Dynamics

(2015) H. Gilbert Welch et al.   NEW ENGLAND JOURNAL OF MEDICINE

The significance of circulating tumor cells in prostate cancer patients undergoing adjuvant or salvage radiation therapy

(2015) L E Lowes et al.   PROSTATE CANCER AND PROSTATIC DISEASES

MgO nanoparticles as antibacterial agent: preparation and activity

(2014) Zhen-Xing Tang et al.   BRAZILIAN JOURNAL OF CHEMICAL ENGINEERING

Insight into nanoparticle cellular uptake and intracellular targeting

(2014) Basit Yameen et al.   JOURNAL OF CONTROLLED RELEASE

High-risk prostate cancer—classification and therapy

(2014) Albert J. Chang et al.   Nature Reviews Clinical Oncology

Folate targeted PEGylated titanium dioxide nanoparticles as a nanocarrier for targeted paclitaxel drug delivery

(2013) G. Devanand Venkatasubbu et al.   ADVANCED POWDER TECHNOLOGY

Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells

(2013) Cristian Vilos et al.   BIOMATERIALS

Mortality response of folate receptor-activated, PEG–functionalized TiO2 nanoparticles for doxorubicin loading with and without ultraviolet irradiation

(2013) Sanaz Naghibi et al.   CERAMICS INTERNATIONAL

Effect of Polyethylene Glycol Modification of TiO2 Nanoparticles on Cytotoxicity and Gene Expressions in Human Cell Lines

(2012) Sharmy Saimon Mano et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Study of Interaction Between PEG Carrier and Three Relevant Drug Molecules: Piroxicam, Paclitaxel, and Hematoporphyrin

(2012) Yen-Chin Li et al.   JOURNAL OF PHYSICAL CHEMISTRY B

A new nano-cryosurgical modality for tumor treatment using biodegradable MgO nanoparticles

(2012) De-Rui Di et al.   Nanomedicine-Nanotechnology Biology and Medicine

Encapsulation of 2-methoxyestradiol within multifunctional poly(amidoamine) dendrimers for targeted cancer therapy

(2011) Yin Wang et al.   BIOMATERIALS

Nanoparticle PEGylation for imaging and therapy

(2011) Jesse V Jokerst et al.   Nanomedicine

Global Patterns of Cancer Incidence and Mortality Rates and Trends

(2010) A. Jemal et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Therapeutic Promises of 2-Methoxyestradiol and Its Drug Disposition Challenges

(2010) Svetlana Verenich et al.   MOLECULAR PHARMACEUTICS

2-Methoxyestradiol—Biology and mechanism of action

(2010) A.O. Mueck et al.   STEROIDS